GLP-1 Medications · Prescription Required

Weight Loss Injections Australia: What You Need to Know

GLP-1 medications are changing the landscape of medically supervised weight management in Australia. A plain-English guide to how they work, what's available, and how to access them.

Check My Eligibility Medications Available
ARTG-RegisteredMedications only
Pharmacist DispensedAHPRA registered
Home DeliverySame-day available

Clinically supervised weight management

100K+
Patients nationally
4.8★
Average rating
Same-Day
Metro delivery
24/7
Script management
Overview

What Are Weight Loss Injections?

Prescription medications administered by subcutaneous injection, now clinically available in Australia for medically supervised weight management.

Weight loss injections refer to a class of prescription medications that are self-administered subcutaneously (under the skin) and are used as part of a clinically supervised weight management plan. They are not surgical procedures, nor are they the same as lipotropic injections or other cosmetic treatments.

The most clinically significant class currently available in Australia are GLP-1 receptor agonists — medications that mimic a naturally occurring gut hormone (GLP-1) involved in appetite regulation and glucose metabolism. Some newer agents, such as Mounjaro (tirzepatide), also activate GIP receptors alongside GLP-1 receptors.

All weight loss injection medications available through Australian pharmacies are prescription-only (Schedule 4). They require a clinical assessment and a valid prescription from a registered medical practitioner before they can be dispensed.

Important: Weight loss injections are not a standalone solution. They are part of a broader medically supervised care plan that includes clinical assessment, ongoing monitoring, and lifestyle support.
Available in Australia

Prescription Weight Loss Injections

ARTG-registered options available through registered Australian pharmacies. All require prescription and clinical assessment.

Most Common

Semaglutide (Ozempic / Wegovy)

Semaglutide is a GLP-1 receptor agonist available in two forms: Ozempic (0.5mg–2mg, primarily for type 2 diabetes) and Wegovy (2.4mg, specifically approved for weight management). Both are once-weekly injections.

  • Once-weekly self-administered injection
  • Wegovy specifically registered on the ARTG for weight management
  • Studied in the STEP clinical trial programme
  • Prescription required — clinical assessment needed

GLP-1 Receptor Agonist

Works via GLP-1 receptors involved in appetite regulation and glucose metabolism

Dual Mechanism

Tirzepatide (Mounjaro)

Mounjaro is a dual GIP/GLP-1 receptor agonist — meaning it activates two receptor types rather than one. It is registered on the Australian Register of Therapeutic Goods (ARTG) and represents a newer class of medication for weight management. Once-weekly injection.

  • Dual GIP/GLP-1 mechanism — activates two receptors
  • Registered on the ARTG
  • Studied in the SURMOUNT trial programme
  • Prescription required — clinical assessment needed

Dual GIP + GLP-1 Agonist

Activates both GIP and GLP-1 receptors — a distinct mechanism from single-agent GLP-1 medications

The Process

How to Access Weight Loss Injections

A medically supervised pathway from assessment to delivery.

1

Health Assessment

Complete a confidential assessment covering your health history and circumstances.

2

Clinician Review

An authorised prescriber determines what, if any, prescription is clinically appropriate.

3

Prescription Dispensed

A licensed pharmacist reviews and dispenses your prescription with safety checks.

4

Delivery

Medication delivered to your door. Same-day delivery available in metro areas.

Eligibility

Are Weight Loss Injections Right for You?

Eligibility is a clinical determination — not a consumer checklist. Your prescriber evaluates your full circumstances.

Prescription weight loss injections are typically considered for adults where lifestyle modifications alone have been insufficient, and where a clinical assessment supports the use of prescription treatment. They are not appropriate for everyone, and the prescribing decision rests entirely with a registered Australian medical practitioner.

Clinical guidelines for GLP-1 weight management medications generally reference:

  • A BMI of 30 kg/m² or greater, OR
  • A BMI of 27 kg/m² or greater with at least one weight-related comorbidity (e.g. type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea)
Important: These are reference criteria from clinical guidelines — not a guaranteed eligibility threshold. The prescriber makes the prescribing decision based on your complete health assessment. Additional contraindications, drug interactions, and clinical factors are also considered. Not everyone who meets these criteria will receive a prescription.

The free eligibility assessment is the clearest way to find out whether prescription weight loss injections may be clinically appropriate for your circumstances. An authorised prescriber reviews your assessment and makes a clinical determination.

Safety & side effects

Safety Overview

All prescription weight loss injections available through Chemist2U are registered on the ARTG. Side effect profiles vary by medication and individual.

All GLP-1 and dual GIP/GLP-1 medications dispensed through Chemist2U's partner pharmacy network are registered on the Australian Register of Therapeutic Goods (ARTG) — meaning they have passed the TGA's rigorous evaluation of safety, quality, and efficacy data before being registered for use.

Common side effects

The most commonly reported side effects across GLP-1 and GIP/GLP-1 medications include:

  • Nausea — the most frequently reported side effect, particularly during dose escalation. Often reduces as the body adjusts.
  • Vomiting, diarrhoea, and constipation — gastrointestinal effects are common and generally transient.
  • Injection site reactions — mild redness, bruising, or discomfort at the injection site are occasionally reported.
Full side effect information: The TGA-approved Consumer Medicine Information (CMI) for each specific medication contains a complete list of potential side effects, contraindications, and drug interactions. CMI documents are available from your dispensing pharmacist. Your pharmacist will also conduct drug interaction screening at the time of dispensing.

When to seek advice

If you experience side effects that are persistent, severe, or unexpected, contact your pharmacist or prescriber promptly. Do not stop or modify any prescription medication without consulting your clinician first.

Common Questions

Frequently Asked Questions

What are weight loss injections?

Weight loss injections are prescription medications administered via subcutaneous injection that work to support clinically supervised weight management. The most common class available in Australia are GLP-1 receptor agonists — including Ozempic, Mounjaro, Wegovy, and Saxenda. They are not the same as surgical injections or cosmetic treatments.

Are weight loss injections available in Australia?

Yes. Several ARTG-registered weight loss injection medications are available in Australia with a valid prescription from a registered medical practitioner. These include semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro), and liraglutide (Saxenda).

Do I need a prescription for weight loss injections?

Yes. All weight loss injection medications available in Australia are Schedule 4 (S4) prescription-only medicines. They require a valid prescription from a registered medical practitioner following a clinical assessment.

How do weight loss injections work?

GLP-1 receptor agonists — the most common class of weight loss injection — work by mimicking a naturally occurring hormone (GLP-1) that plays a role in appetite regulation, gastric emptying, and glucose metabolism. Mounjaro (tirzepatide) also activates GIP receptors, giving it a dual mechanism of action.

Are weight loss injections safe?

All weight loss injections available through Chemist2U are registered on the Australian Register of Therapeutic Goods (ARTG). Common side effects include nausea, vomiting, and gastrointestinal discomfort, particularly during dose escalation. A full safety profile is available in the TGA-approved Consumer Medicine Information for each specific medication. Your prescriber and pharmacist will discuss safety considerations based on your individual health profile.

How much do weight loss injections cost in Australia?

Costs vary by medication, dose, and whether you have a PBS-eligible indication. Ozempic has PBS listing for type 2 diabetes; Wegovy and Mounjaro for weight management are typically accessed privately. Your prescriber or pharmacist can provide current pricing.

Dr Matthew Cullen

MBBS · Founder & CEO, Chemist2U

Dr Matthew Cullen is the founder and CEO of Chemist2U and a medical doctor (MBBS). This page has been reviewed for clinical accuracy and compliance with TGA therapeutic goods advertising requirements. Last reviewed May 2026.

Important Information

The information on this page is provided for general informational purposes only. It does not constitute medical advice and does not advertise or promote the use of any specific prescription medication. Prescription medications can only be accessed after a clinical consultation with an authorised medical practitioner.

All prescriptions are issued at the discretion of the consulting clinician in accordance with Australian medical guidelines and regulatory requirements. All dispensing is carried out by AHPRA-registered pharmacists. Individual eligibility and clinical suitability is determined by the treating clinician.

If you are experiencing a medical emergency, call 000. For health concerns, consult your GP or healthcare provider.

Last reviewed: May 2026 · Compliance: TGA Therapeutic Goods Advertising Code

Ready to Find Out If You’re Eligible?

Start a confidential health assessment to find out if prescription weight management treatment may be right for you.

Check My Eligibility